Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

BioSyent to Present at Upcoming Investor Conferences


TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent") (TSX Venture:RX) is pleased to announce that it will be presenting at the following upcoming investor conferences:

May 2, 2018 - Bloom Burton & Co. Healthcare Investor Conference at the Sheraton Centre Hotel Toronto, Toronto, Ontario.  Mr. René Goehrum, BioSyent's President and CEO, will present to investors an overview of BioSyent's business and corporate activities on Wednesday, May 2nd at 2:30 p.m. ET.  Mr. Goehrum and Mr. Peter Weiler, BioSyent's Vice President of Business Development, will also be available to meet with investors on a one-on-one basis during the conference on May 2nd and 3rd. These one-on-one meetings can be requested by attendees through the online conference portal: https://www.bloomburton.com/bloom-burton-co-healthcare-investor-conference/.

May 10, 2018 ? East Coast IDEAS Investor Conference at the Boston Park Plaza, Boston, Massachusetts.  Mr. Goehrum will present to investors on Thursday, May 10th at 9:50 a.m. ET.  The audio portion of the presentation will be webcast live and will be available for playback for 30 days following the presentation at the following link: http://www.wsw.com/webcast/threepa25/bioyf.  Mr. Goehrum will also be available for one-on-one meetings during the day on May 10th.  Interested investors can request meetings with Mr. Goehrum through the online conference platform: https://www.meetmax.com/sched/event_48311/entity_login.html?attendee_role_id=COMPANY.

About BioSyent Inc.

Listed on the TSX Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients.  BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, hospital and international business units.

As of the date of this press release, the Company has 14,509,095 common shares issued and outstanding.

For a direct market quote for the TSX Venture Exchange and other Company financial information please visit www.tmxmoney.com.

For further information please contact:

Mr. René C. Goehrum
President and CEO
BioSyent Inc.
Tel: (905) 206-0013
E-Mail: [email protected]
Web: www.biosyent.com


These press releases may also interest you

at 09:48
Perspire Sauna Studio, one of the country's largest sauna franchises specializing in full spectrum infrared (IR) and red-light therapy (RLT), is rolling out a new sauna design and member experience through the brand's long-standing partnership with...

at 09:38
The Kinetix Group (TKG) and Pfizer Inflammation and Immunology received a PM360 Pharma Choice Award for their recent health equity initiative. The award recognized Pfizer's atopic dermatitis interactive guide for varying skin tones....

at 09:37
Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China and the United States, today announced it has been granted a new Class III certificate by the National...

at 09:15
101 Mobility® is thrilled to announce the opening of its newest location in Eden Prairie, marking the introduction of the city's first nationally branded full-service provider of a wide range of mobility equipment. This includes stair lifts, ramps,...

at 09:15
Vibrant Wellness, a leader in specialized diagnostics and personalized health tools, announced today that its Tickborne Testing received approval from The Wadsworth Center, part of the New York State Department of Health.This approval enables Vibrant...

at 09:07
Olympus announced today that it has been awarded a contract for its advanced energy portfolio by Provista Inc. This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the...



News published on and distributed by: